Correspondence to Dr Lai-Shan Tam, Department of Medicine & Therapeutics, The Chinese University of Hong Kong, Hong Kong, Hong Kong; lstam{at}cuhk.edu.hk Objective To evaluate the effects of denosumab ...
Objective: To validate and refine two sets of candidate criteria for the classification/diagnosis of axial spondyloarthritis (SpA). Methods: All Assessment of SpondyloArthritis international Society ...
Objectives Although MRI data supports a link between spinal inflammation and formation of new bone in ankylosing spondylitis, anti-tumour necrosis factor α therapies have not been shown to prevent new ...
Dr B Manger, Department of Internal Medicine III, University Erlangen Krankenhausstr 12, D-91054 Erlangen, Germany Newer US techniques, which are currently being evaluated, include colour and power ...
2 Clinical Immunology and Analgesia, Merck Research Laboratories, Rahway, USA Correspondence to: Dr S P Curtis Merck Research Laboratories, PO Box 2000, Rahway, New Jersey, USA; ...
Objectives To update the 2017 European Alliance of Associations for Rheumatology (EULAR) recommendations for treatment of systemic sclerosis (SSc), incorporating new evidence and therapies. Methods An ...
Assessing the performance of AI chatbots in answering patients’ common questions about low back pain
Objectives The aim of this study was to assess the accuracy and readability of the answers generated by large language model (LLM)-chatbots to common patient questions about low back pain (LBP).
Objective Varus and valgus alignment increase medial and lateral tibiofemoral load. Alignment was associated with tibiofemoral osteoarthritis progression in previous studies; an effect on incident ...
Department of Laboratory Diagnostics, Changzheng Hospital, Second Military Medical University, Shanghai, China Correspondence to Dr Yang Zaixing and Professor Renqian Zhong, Department of Laboratory ...
Correspondence to Siri Lillegraven, Department of Rheumatology, Diakonhjemmet Hospital, Box 23 Vinderen, N-0319 Oslo, Norway; siri.lillegraven{at}gmail.com In secondary analyses, focusing on vdHSS and ...
‘Poly-refractory’ disease affects 2.7% of patients with rheumatoid arthritis (RA) who have failed different groups of biologic disease-modifying antirheumatic drugs (b-DMARDS) and targeted synthetic ...
We read with interest the recent article by Singh and Cleveland on the hypersensitivity risk of allopurinol (ALP) and febuxostat (FBX) compared with colchicine.1 A common challenge when using ALP, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results